On May 16 at 12:00pm ET, CSR will host a public event focused on this critical area of progress in U.S. biomanufacturing resilience.
Biological threats to national security pose a unique combination of risk and opportunity, with the potential for large-scale damage and the bargain of mitigating them.
CSR’s Dan Regan talks to IBBIS Executive Director Piers Millett on the Biological Weapons Convention, the future of its implementation, and how verification could be pursued amid shifting technologies.
Habitat fragmentation, ecosystem degradation, land conversion, deforestation, and wildlife trade have all contributed to the steady increase in disease spillover over the past several decades.
Taking steps now to enhance surveillance, accelerate vaccine testing and development, and improve the security of farms, will help prevent H5N1 from becoming the next pandemic. It is not too late to tackle this threat, but it is ultimately up to us to take action.
This report summarizes discussions held during a workshop hosted by the Council on Strategic Risks on September 26, 2022, focused on ending extreme risks from biological threats. Conversations centered around a few core subject areas: pathogen early warning, public-private collaboration, interagency efforts and collaboration, and strategic communications.
CSR is announcing a call for applications for the 2023–2024 class of our Fellowship for Ending Bioweapons.
NSABB’s recommendations cover research involving enhanced pandemic potential pathogens, as well as dual-use research of concern.
The Council on Strategic Risks seeks to hire a full-time team member focused on addressing biological threats. This may be a Fellow or Senior Fellow role, depending on the expertise of the applicants.
DoD’s major update for its Chemical and Biological Defense Program outlines a new, two-phased approach to medical countermeasures implementation. But